Related Experiment Videos

New perspectives in the diagnosis of systemic fungal infections

M D Richardson1, M H Kokki

  • 1Department of Bacteriology and Immunology, Haartman Institute, University of Helsinki, Finland. malcolm.richardson@helsinki.fi

Annals of Medicine
|November 26, 1999
PubMed

Insights

Profound neutropenia post-chemotherapy increases risks of systemic fungal infections. Early diagnosis using new methods like PCR is crucial for timely treatment and reducing mortality in at-risk patients.

Area of Science:

  • Mycology
  • Infectious Diseases
  • Oncology

Background:

  • Profound and prolonged neutropenia, often following chemotherapy, significantly elevates the risk of systemic fungal infections.
  • Disseminated fungal infections carry a high mortality rate, and conventional treatments like amphotericin B are limited by renal toxicity.
  • Candida and Aspergillus species are primary fungal pathogens in immunocompromised patients, necessitating effective antifungal strategies.

Purpose of the Study:

  • To review the challenges in diagnosing invasive fungal infections in neutropenic patients.
  • To highlight the limitations of current diagnostic methods and the need for improved early detection.
  • To discuss emerging diagnostic approaches and their potential impact on patient management.

Main Methods:

  • Literature review of diagnostic strategies for invasive fungal infections.
  • Analysis of new diagnostic technologies, including antigen detection and polymerase chain reaction (PCR).
  • Discussion of the role of understanding fungal pathogenesis and virulence factors in diagnostic development.

Main Results:

  • Current clinical and laboratory diagnoses lack sensitivity and specificity for early detection of invasive fungal infections.
  • New diagnostic approaches, such as antigen detection and PCR, show promise for improved early identification.
  • Enhanced monitoring and understanding of fungal pathogens are vital for managing these infections.

Conclusions:

  • Early and accurate diagnosis of systemic fungal infections is critical for guiding appropriate treatment and reducing mortality.
  • Development and implementation of novel diagnostic tests are essential for definitive diagnosis in high-risk neutropenic patients.
  • Translating new diagnostic technologies into routine practice will improve patient outcomes and survival rates.

Related Concept Videos

Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...